Lesley Mitchell

7.1k total citations · 1 hit paper
119 papers, 5.2k citations indexed

About

Lesley Mitchell is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lesley Mitchell has authored 119 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Hematology, 46 papers in Internal Medicine and 33 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lesley Mitchell's work include Blood Coagulation and Thrombosis Mechanisms (80 papers), Venous Thromboembolism Diagnosis and Management (46 papers) and Central Venous Catheters and Hemodialysis (20 papers). Lesley Mitchell is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (80 papers), Venous Thromboembolism Diagnosis and Management (46 papers) and Central Venous Catheters and Hemodialysis (20 papers). Lesley Mitchell collaborates with scholars based in Canada, United States and Germany. Lesley Mitchell's co-authors include Maureen Andrew, M Andrew, Christoph Male, Anthony K.C. Chan, Stefan Kuhle, Frederick A. Ofosu, Bosco Paes, Patricia Vegh, Ulrike Nowak‐Göttl and Valerie P. Castle and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Lesley Mitchell

117 papers receiving 5.0k citations

Hit Papers

Development of the human coagulation system in the health... 1988 2026 2000 2013 1988 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley Mitchell Canada 42 3.2k 2.3k 1.2k 1.1k 963 119 5.2k
M Andrew Canada 30 3.5k 1.1× 2.1k 0.9× 1.3k 1.1× 1.1k 1.0× 646 0.7× 66 5.6k
Ulrike Nowak‐Göttl Germany 50 6.4k 2.0× 3.5k 1.5× 1.9k 1.6× 1.6k 1.5× 786 0.8× 229 9.0k
Neil A. Goldenberg United States 39 3.5k 1.1× 4.5k 1.9× 2.1k 1.8× 1.9k 1.8× 1.5k 1.6× 232 7.5k
Peter Powers Canada 26 1.8k 0.6× 2.9k 1.2× 2.1k 1.8× 1.5k 1.4× 469 0.5× 34 4.9k
Christoph Male Austria 34 2.2k 0.7× 973 0.4× 550 0.5× 622 0.6× 516 0.5× 152 3.7k
Elizabeth Chalmers United Kingdom 30 2.7k 0.9× 943 0.4× 608 0.5× 514 0.5× 320 0.3× 69 3.9k
Gili Kenet Israel 37 4.1k 1.3× 1.1k 0.5× 566 0.5× 601 0.6× 289 0.3× 223 5.5k
Leonardo R. Brandão Canada 28 1.3k 0.4× 1.1k 0.5× 697 0.6× 764 0.7× 430 0.4× 151 2.6k
Ted Koster Netherlands 26 7.0k 2.2× 4.2k 1.8× 2.2k 1.8× 1.1k 1.0× 134 0.1× 46 9.2k
Franco Piovella Italy 34 1.3k 0.4× 4.7k 2.0× 3.3k 2.7× 1.9k 1.7× 954 1.0× 90 6.3k

Countries citing papers authored by Lesley Mitchell

Since Specialization
Citations

This map shows the geographic impact of Lesley Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Mitchell more than expected).

Fields of papers citing papers by Lesley Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Mitchell. The network helps show where Lesley Mitchell may publish in the future.

Co-authorship network of co-authors of Lesley Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Mitchell. A scholar is included among the top collaborators of Lesley Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Mitchell. Lesley Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Albisetti, Manuela, Igor Tartakovsky, Jacqueline Halton, et al.. (2024). Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease. Journal of the American Heart Association. 13(4). e028957–e028957. 4 indexed citations
3.
Dietrich, Kevin, Zhenning Wang, Sarah H. O’Brien, et al.. (2023). OC 38.2 Acquired Abnormalities in the Hemostatic System during Induction Chemotherapy in Treatment of Childhood Acute Lymphoblastic Leukemia (ALL): A Biomarker Sub-Study of the PREVAPIX-ALL Trial. Research and Practice in Thrombosis and Haemostasis. 7. 100522–100522. 1 indexed citations
4.
Brandão, Leonardo R., Igor Tartakovsky, Manuela Albisetti, et al.. (2022). Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia. Blood Advances. 6(22). 5908–5923. 4 indexed citations
5.
Albisetti, Manuela, Igor Tartakovsky, Jacqueline Halton, et al.. (2021). Abstract 9192: Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children With Congenital Heart Disease. Circulation. 144(Suppl_1). 1 indexed citations
6.
Brandão, Leonardo R., Manuela Albisetti, Lisa Bomgaars, et al.. (2019). Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. Blood. 135(7). 491–504. 64 indexed citations
7.
Albisetti, Manuela, Branislav Biss, Lisa Bomgaars, et al.. (2018). Design and rationale for the DIVERSITY study: An open‐label, randomized study of dabigatran etexilate for pediatric venous thromboembolism. Research and Practice in Thrombosis and Haemostasis. 2(2). 347–356. 13 indexed citations
8.
Dietrich, Kevin, et al.. (2015). Assessing the anticoagulant effect of dabigatran in children: An in vitro study. Thrombosis Research. 135(4). 630–635. 30 indexed citations
9.
Lobmeyer, Maximilian T., Thorsten Lehr, Jacqueline Halton, et al.. (2014). Abstract 18482: Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Adolescents: An Open-label Phase IIa Study. Circulation. 130. 1 indexed citations
10.
11.
Kuhle, Stefan, Maria Spavor, Patricia Massicotte, et al.. (2008). Prevalence of post‐thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia. Journal of Thrombosis and Haemostasis. 6(4). 589–594. 59 indexed citations
12.
Kuhle, Stefan, Pablo Eulmesekian, Brian P. Kavanagh, et al.. (2007). A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study. Haematologica. 92(2). 244–247. 60 indexed citations
13.
Male, Christoph, et al.. (2005). Significant association with location of central venous line placement and risk of venous thrombosis in children. Thrombosis and Haemostasis. 94(9). 516–521. 81 indexed citations
14.
Monagle, Paul, et al.. (2003). Fibrinolytic System in Adolescents: Response to Venous Occlusion Stress Tests. Pediatric Research. 53(2). 333–337. 16 indexed citations
15.
Puri, Basant K., Graeme M. Bydder, К. Ray Chaudhuri, et al.. (2001). MRI changes in multiple sclerosis following treatment with lofepramine and l-phenylalanine. Neuroreport. 12(9). 1821–1824. 24 indexed citations
16.
Streif, Werner, Lesley Mitchell, & Maureen Andrew. (1999). Antithrombotic therapy in children. Current Opinion in Pediatrics. 11(1). 47–64. 31 indexed citations
17.
Schmidt, Barbara, et al.. (1998). A Placebo-controlled Randomized Trial of Antithrombin Therapy in Neonatal Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 158(2). 470–476. 40 indexed citations
18.
Mitchell, Lesley, Anton H. Sutor, & Maureen Andrew. (1995). Hemostasis in Childhood Acute Lymphoblastic Leukemia: Coagulopathy Induced by Disease and Treatment. Seminars in Thrombosis and Hemostasis. 21(4). 390–401. 72 indexed citations
20.
Andrew, M, Hugh OʼBrodovich, & Lesley Mitchell. (1988). Fetal lamb coagulation system during birth asphyxia. American Journal of Hematology. 28(3). 201–203. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026